Impellizzeri Franco M, Bizzini Mario, Leunig Michael, Maffiuletti Nicola A, Mannion Anne F
Department of Research and Development, Schulthess Klinik, Lengghalde 2, 8008 Zurich, Switzerland.
Eur Spine J. 2009 Aug;18 Suppl 3(Suppl 3):348-59. doi: 10.1007/s00586-009-0929-5. Epub 2009 Mar 18.
In recent years, there has been an increase in studies that have sought to identify predictors of treatment outcome and to examine the efficacy of surgical and non-surgical treatments. In addition to the scientific advancement associated with these studies per se, the hospitals and clinics where the studies are conducted may gain indirect financial benefit from participating in such projects as a result of the prestige derived from corporate social responsibility, a reputational lever used to reward such institutions. It is known that there is a positive association between corporate social performance and corporate financial performance. However, in addition to this, the research findings and the research staff can constitute resources from which the provider can reap a more direct benefit, by means of their contribution to quality control and improvement. Poor quality is costly. Patient satisfaction increases the chances that the patient will be a promoter of the provider to friends and colleagues. As such, involvement of the research staff in the improvement of the quality of care can ultimately result in economic revenue for the provider. The most advanced methodologies for continuous quality improvement (e.g., six-sigma) are data-driven and use statistical tools similar to those utilized in the traditional research setting. Given that these methods rely on the application of the scientific process to quality improvement, researchers have the adequate skills and mind-set to embrace them and thereby contribute effectively to the quality team. The aim of this article is to demonstrate by means of real-life examples how to utilize the findings of outcome studies for quality management in a manner similar to that used in the business community. It also aims to stimulate research groups to better understand that, by adopting a different perspective, their studies can be an additional resource for the healthcare provider. The change in perspective should stimulate researchers to go beyond the traditional studies examining predictors of treatment outcome and to see things instead in terms of the "bigger picture", i.e., the improvement of the process outcome, the quality of the service.
近年来，旨在确定治疗结果预测因素并检验手术和非手术治疗效果的研究有所增加。除了这些研究本身带来的科学进步外，开展这些研究的医院和诊所可能会因企业社会责任带来的声誉而从参与此类项目中获得间接经济利益，企业社会责任是用于奖励此类机构的声誉杠杆。众所周知，企业社会绩效与企业财务绩效之间存在正相关关系。然而，除此之外，研究结果和研究人员可以构成资源，提供者可以通过他们对质量控制和改进的贡献从中获得更直接的利益。质量差成本高昂。患者满意度会增加患者向朋友和同事推荐提供者的可能性。因此，研究人员参与提高护理质量最终可为提供者带来经济收益。持续质量改进的最先进方法（如六西格玛）以数据为驱动，使用与传统研究环境中使用的统计工具类似的工具。鉴于这些方法依赖于将科学过程应用于质量改进，研究人员具备足够的技能和思维方式来接受它们，从而有效地为质量团队做出贡献。本文的目的是通过实际例子展示如何以类似于商业界的方式利用结果研究的结果进行质量管理。它还旨在激励研究团队更好地理解，通过采用不同的视角，他们的研究可以成为医疗保健提供者的额外资源。视角的转变应促使研究人员超越传统的研究治疗结果预测因素的范畴，而是从“大局”的角度看待问题，即过程结果的改善、服务质量的提高。
